NCT06020807
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Urology San Antonio San Antonio, Texas, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,957 public trials
633 recruiting studies
Urologic Neoplasms trial results
NCT03200717
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Novartis Investigative Site Caba, Buenos Aires, Argentina
- Novartis Investigative Site Graz, Austria
- Novartis Investigative Site Salzburg, Austria
NCT02426125
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- St. Jude Medical Center Fullerton, California, United States
- UCLA Medical Center Los Angeles, California, United States
- USC Norris Cancer Hospital Los Angeles, California, United States
NCT05025748
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
- Locations
-
- Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
- Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
Completed
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
NCT02756637
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT00471432
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +49 more
- Locations
-
Not specified
NCT00075660
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
Completed
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT02855203
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT05314582
- Conditions
- Blood Transfusion Complication, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
- Locations
-
- Bezmialem Vakif University Istanbul, Turkey (Türkiye)
NCT01689766
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Baylor College of Medicine Houston, Texas, United States